![Rod Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rod Wong
Direktor/Vorstandsmitglied bei
ROCKET PHARMACEUTICALS, INC.
Vermögen: 111 Mio $ am 31.05.2026
Profil
Dr. Roderick T.
Wong is a Managing Partner & Chief Investment Officer at RTW Investments LP and a Managing Partner & Chief Investment Officer at RTW Investments LP /Venture Capital/.
He is on the Board of Directors at NiKang Therapeutics, Inc., Attune Pharmaceuticals, Inc. and Rocket Pharmaceuticals, Inc. Dr. Wong was previously employed as an Independent Director by Avidity Biosciences, Inc., an Independent Director by Landos Biopharma, Inc., a Chairman, President & Chief Executive Officer by Health Sciences Acquisitions Corp., a Chairman by Rocket Pharmaceuticals Ltd., a Research Associate by Cowen & Co. (New York), and a Principal by Davidson Kempner Capital Management LLC.
He also served on the board at Penwest Pharmaceuticals Co., CORXEL Pharmaceuticals (Shanghai) Co., Ltd. and Health Sciences Acquisitions Corp.
2.
He received his undergraduate degree from Duke University, an MBA from Harvard Business School and a doctorate degree from Perelman School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RTW Biotech Opportunities Ltd.
 RTW Biotech Opportunities Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a venture capital fund 15,34 % | 27.03.2025 | 50.356.880 ( 15,34 % ) | 111 Mio $ | 31.05.2026 |
| 24.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Rod Wong
| Unternehmen | Position | Beginn |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients | Direktor/Vorstandsmitglied | 01.09.2020 |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Chief Investment Officer | - |
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW aims to generate attractive risk-adjusted returns through investments in securities, both equity and debt, long and short, of companies with a focus on the healthcare sector. The Funds primarily invest in the equity and debt of public and private issuers globally, with a focus on the US and Europe. Derivatives are employed to improve payoff structures, as well as to construct hedges. | Vorstandsvorsitzender | 01.02.2010 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Direktor/Vorstandsmitglied | 01.06.2018 |
Ehemalige bekannte Positionen von Rod Wong
| Unternehmen | Position | Ende |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 07.06.2022 |
| AVIDITY BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 25.08.2021 |
| IMMUNOVANT, INC. | Vorstandsvorsitzender | 01.12.2019 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Vorsitzender | 01.01.2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Rod Wong
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Cowen & Co. (New York)
 Cowen & Co. (New York) Investment Banks/BrokersFinance Provides security brokerage services | Finance |
Davidson Kempner Capital Management LP
 Davidson Kempner Capital Management LP Investment ManagersFinance DKCM invests client assets using a variety of arbitrage and other event-driven strategies, including risk arbitrage transactions and investments in financially distressed companies. The firm's primary investment strategies include distressed investing, mergers and acquisitions (or risk) arbitrage, long/short equities, and convertible and volatility arbitrage. As distressed investment opportunities are identified, they are subjected to rigorous, fundamental, bottom-up analysis. | Finance |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
RTW Investments LP
RTW Investments LP Investment ManagersFinance RTW aims to generate attractive risk-adjusted returns through investments in securities, both equity and debt, long and short, of companies with a focus on the healthcare sector. The Funds primarily invest in the equity and debt of public and private issuers globally, with a focus on the US and Europe. Derivatives are employed to improve payoff structures, as well as to construct hedges. | Finance |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Health Technology |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Commercial Services |
Health Sciences Acquisitions Corp.
 Health Sciences Acquisitions Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Finance |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients | Health Technology |
Health Sciences Acquisitions Corp. 2
 Health Sciences Acquisitions Corp. 2 Financial ConglomeratesFinance Operates as a blank check company | Finance |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Health Technology |
